Amazon Biotech, Inc. Announces Submitting of a Protocol to Test AMZ0026 as an HIV Drug to Delay Onset of AIDS With the FDA
April 18, 2006 16:53 ET
|
Amazon Biotech, Inc.
NEW YORK, April 18, 2006 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced that it has filed a protocol to test AMZ0026 as an HIV drug to delay onset of full-blown AIDS with the Food...
Amazon Biotech Announces Development of a Redesigned HIV Protocol to Test AMZ0026 as an Add-On to Conventional HAART Therapy in HIV-1 Seropositive Pre-AIDS Subjects
April 04, 2006 08:24 ET
|
Amazon Biotech, Inc.
NEW YORK, April 4, 2006 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced that it is redesigning its protocol for phase I/II trials to test AMZ0026 as an antiviral and immunomodulatory...
Amazon Biotech Announces Preparation of a Protocol to Test AMZ0026 as an HIV Drug to Delay Onset of Full-Blown AIDS
March 28, 2006 17:53 ET
|
Amazon Biotech, Inc.
NEW YORK, March 28, 2006 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced that it is designing a protocol to test AMZ0026 as an HIV drug to delay onset of full-blown AIDS. The study is...
Amazon Biotech, Inc. Announces the Rights to Acquire EZ Orthopedics Inc.
August 02, 2005 08:30 ET
|
Amazon Biotech, Inc.
NEW YORK, Aug. 2, 2005 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced that it has acquired the rights to purchase a controlling interest in EZ Orthopedics, a medical orthopedics...
Amazon Biotech Announces It Has Raised $600,000 to Advance Product Development and Seeks Up to $6 Million in Additional Capital
March 14, 2005 08:30 ET
|
Amazon Biotech, Inc.
NEW YORK, March 14, 2005 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB), a developer and producer of AMZ 0026, a potential immunomodulator drug developed for use in the treatment of the HIV virus,...
Amazon Biotech, Inc. Announces the Appointment of Dr. Kathleen K. Casey, M.D., F.A.C.P., F.I.D.S.A. to its Scientific Advisory Board to Assist in the Phase I/II Study on AMZB Drug for AIDS AMZ0026
March 08, 2005 14:55 ET
|
Amazon Biotech, Inc.
NEW YORK, March 8, 2005 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced the appointment of Kathleen K. Casey, M.D., F.A.C.P., F.I.D.S.A. to its Scientific Advisory Board.
Dr. Casey...
Amazon Biotech, Inc. Announces the Appointment of Dr. Anthony J. Mangia, M.D., F.A.C.P to its Scientific Advisory Board to Assist in the Phase I/II on AMZB Drug for AIDS AMZ0026
January 19, 2005 09:54 ET
|
Amazon Biotech, Inc.
NEW YORK, Jan. 19, 2005 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced the appointment of Anthony J. Mangia, M.D., F.A.C.P, to its Scientific Advisory Board.
Dr. Mangia has over...
Amazon Biotech, Inc. Announces the Appointment of Dr. Arthur Englard to Its Scientific Advisory Board
August 25, 2004 08:46 ET
|
Amazon Biotech, Inc.
NEW YORK, Aug. 25, 2004 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced the appointment of Arthur Englard M.D., Ph.D., to its Scientific Advisory Board.
Dr. Englard is an Assistant...
Amazon Biotech Inc. Retains Strategic Growth as Investor Relations Advisor
July 07, 2004 08:41 ET
|
Amazon Biotech, Inc.
NEW YORK, July 7, 2004 (PRIMEZONE) -- Amazon Biotech Inc. (OTCBB:AMZB), a New York-based pharmaceutical company engaged in the development of novel all-natural drugs, announced it has retained...
Amazon Biotech Inc. Announces the Appointment of Dr. Angelo Chinicci, as Company Chief Executive Officer
April 15, 2004 09:16 ET
|
Amazon Biotech, Inc.
NEW YORK, April 15, 2004 (PRIMEZONE) -- Amazon Biotech Inc. (OTCBB:AMZB) today announced the appointment of Dr. Angelo A. Chinnici as Company Chief Officer. Dr. Chinicci has been in clinical practice...